G S Wu Selected Research

Antibodies

1/2017

Successful Rescue of Late-onset Antibody-mediated Rejection 12 Years After Living-donor Intestinal Transplantation: A Case Report.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

G S Wu Research Topics

Disease

7	Burns 01/2022 - 01/2017
5	Neoplasms (Cancer) 01/2022 - 01/2000
3	Shock 02/2021 - 05/2020
2	Breast Neoplasms (Breast Cancer) 05/2022 - 10/2021
2	Inflammation (Inflammations) 11/2020 - 01/2019
2	Sepsis (Septicemia) 10/2020 - 01/2019
2	Lung Neoplasms (Lung Cancer) 11/2001 - 01/2001
1	Lymphedema (Milroy Disease) 05/2022
1	Fibrosis (Cirrhosis) 05/2022
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 05/2022
1	Pneumonia (Pneumonitis) 05/2022
1	Lung Injury 05/2022
1	Acute Lung Injury 05/2022
1	Inhalation Burns 01/2022
1	Flushing 11/2021
1	Mastitis 11/2021
1	Smoke Inhalation Injury 04/2021
1	Respiratory Tract Infections (Respiratory Tract Infection) 04/2021
1	Wounds and Injuries (Trauma) 04/2021
1	Pulmonary Edema 11/2020
1	Ovarian Neoplasms (Ovarian Cancer) 10/2017
1	Cicatrix (Scar) 01/2017
1	Contracture 01/2017
1	Infections 01/2017
1	Diarrhea 01/2017
1	Intestinal Volvulus (Volvulus) 01/2017
1	Abdominal Abscess 05/2015
1	Colonic Neoplasms (Colon Cancer) 11/2001
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2001
1	Uveitis 01/2000
1	Blindness (Hysterical Blindness) 01/2000

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 10/2017 - 01/2000
2	CytokinesIBA 01/2019 - 01/2000
2	CaspasesIBA 01/2001 - 01/2000
1	AntioxidantsIBA 05/2022
1	Myosins (Myosin)IBA 05/2022
1	LipopolysaccharidesIBA 05/2022
1	EndotoxinsIBA 05/2022
1	Eosine Yellowish-(YS) (Eosin)IBA 05/2022
1	Hematoxylin (Haematoxylon)IBA 05/2022
1	Therapeutic UsesIBA 11/2021
1	PlasticsIBA 11/2021
1	SmokeIBA 04/2021
1	fibrin fragment D (D-dimer)IBA 02/2021
1	formycin diphosphate (FDP)IBA 02/2021
1	Fibrinogen (Factor I)FDA Link 02/2021
1	Hemostatics (Antihemorrhagics)IBA 02/2021
1	Vasoconstrictor AgentsIBA 11/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2020
1	AngiopoietinsIBA 10/2020
1	human AZU1 proteinIBA 10/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2020
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 10/2020
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Platinum Compounds (Compounds, Platinum)IBA 10/2017
1	Cisplatin (Platino)FDA LinkGeneric 10/2017
1	Botulinum Toxins (Botulinum Toxin)IBA 01/2017
1	SiliconesIBA 01/2017
1	AntibodiesIBA 01/2017
1	Messenger RNA (mRNA)IBA 11/2001
1	QuinoxalinesIBA 11/2001
1	Phosphotransferases (Kinase)IBA 11/2001
1	XK 469 (XK469)IBA 11/2001
1	propionic acid (potassium propionate)IBA 11/2001
1	AcidsIBA 11/2001
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2001
1	TNF-Related Apoptosis-Inducing LigandIBA 01/2001
1	Cytochromes c (Cytochrome c)IBA 01/2001
1	Free RadicalsIBA 01/2000
1	Oxidants (Oxidizing Agents)IBA 01/2000
1	Cytotoxins (Cytolysins)IBA 01/2000
1	fas Receptor (CD95 Antigen)IBA 01/2000
1	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 01/2000
1	Retinaldehyde (Retinal)IBA 01/2000
1	Retinal Pigments (Pigments, Visual)IBA 01/2000

Therapy/Procedure

4	Transplantation 05/2022 - 05/2015
4	Tracheotomy 01/2022 - 01/2020
2	Lymph Node Excision (Lymph Node Dissection) 05/2022 - 10/2021
2	Resuscitation 11/2020 - 05/2020
2	Skin Transplantation (Skin Grafting) 11/2020 - 01/2017
2	Therapeutics 01/2017 - 01/2000
1	Autologous Transplantation 01/2022
1	Operative Surgical Procedures 11/2021
1	Length of Stay 04/2021
1	Artificial Respiration (Mechanical Ventilation) 04/2021
1	Emergency Treatment 11/2020
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2017
1	Lasers (Laser) 01/2017
1	Orthotic Devices (Orthosis) 01/2017
1	Tissue Transplantation 01/2017
1	Physical Therapy Modalities (Physical Therapy Technique) 01/2017
1	Molecular Targeted Therapy 01/2017
1	Drug Therapy (Chemotherapy) 05/2001